EUVIMEDEUVIMED entdecken
Kohortenstudie

Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study

Sung Hye Kong iD, Ju-Young Park, Moon-Kyung Shin, Hyo-Jung Lee, Jin Woo Kim, Seung Shin Park, Sang Wan Kim, Chan Soo Shin, Tae-Jin Song iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae850 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Sung Hye Kong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 13620, Republic of Korea. Hauptthemen laut MEDLINE: Diphosphonates, Osteoporotic Fractures, Bone Density Conservation Agents. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Institute of Information & Communications Technology Planning & Evaluation, Korean government, Korea Health Technology R&D Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Fragility fractures in young adults present significant clinical challenges due to the limited evidence on the effectiveness of bisphosphonates in preventing subsequent fractures.

Objective

To evaluate the effectiveness of bisphosphonate therapy in reducing the fracture risk among premenopausal women with a history of osteoporotic fractures.

Design

A population-based retrospective cohort study was conducted using data from the National Health Insurance Service-National Sample Cohort in South Korea, covering the years 2003 to 2014.

Setting

A nationwide healthcare setting utilizing a representative cohort database.

Participants

Among 2087 premenopausal women with osteoporotic fractures, participants were propensity score-matched based on age and body mass index at a 1:3 ratio, resulting in 132 bisphosphonate users and 396 nonusers.

Intervention

Bisphosphonate treatment. Main Outcome Measures The incidence of osteoporotic fractures.

Results

Bisphosphonate users had a significantly lower risk of major osteoporotic fractures [hazard ratio (HR) 0.618, 95% confidence interval (CI) 0.396-0.963] compared to nonusers. Ibandronate users showed significant reductions in both major osteoporotic (HR 0.376, 95% CI 0.164-0.861) and nonvertebral fractures (HR 0.214, 95% CI 0.052-0.877). Also, longer duration of bisphosphonate use (≥180 days) was associated with a significantly lower risk of major osteoporotic and nonvertebral fractures (HR 0.528, 95% CI 0.300-0.929; HR 0.409, 95% CI 0.187-0.895, respectively).

Conclusion

Bisphosphonate therapy significantly reduces fracture risk in premenopausal women with previous osteoporotic fractures, especially at higher cumulative doses. These findings support considering bisphosphonates as a treatment option in premenopausal women at high risk of fractures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiphosphonatesOsteoporotic FracturesBone Density Conservation AgentsHumansFemaleRetrospective StudiesAdultRepublic of KoreaMiddle AgedIncidenceOsteoporosisPremenopauseYoung AdultCohort StudiesTreatment Outcome

Stichwörter der Autor:innen

bisphosphonateseffectivenessfracturesyoung adults

Substanzen

DiphosphonatesBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 13620, Republic of Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
  • Department of Applied Statistics, Yonsei University, Seoul, 03722, Republic of Korea.
  • Department of Statistics and Data Science, Yonsei University, Seoul, 03722, Republic of Korea.
  • Medical Research Institute, Ewha Womans University, College of Medicine, Seoul, 07804, Republic of Korea.
  • Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, 13620, Republic of Korea.

ORCID-Profile: Sung Hye Kong, Tae-Jin Song

Förderung

  • Institute of Information & Communications Technology Planning & Evaluation
  • Korean government
  • Korea Health Technology R&D Project
  • Korea Health Industry Development Institute (KHIDI)
  • Ministry of Health & Welfare, Republic of Korea
  • National Research Foundation of Korea
  • Seoul National University Bundang Hospital

Zitieren

APA

Kong, S. H., Park, J. Y., Shin, M. K., Lee, H. J., Kim, J. W., Park, S. S., Kim, S. W., Shin, C. S., & Song, T. J. (2025). Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae850

Vancouver

Kong SH, Park JY, Shin MK, Lee HJ, Kim JW, Park SS, et al. Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae850

BibTeX
@article{Kong2025,
  author = {Kong, Sung Hye and Park, Ju-Young and Shin, Moon-Kyung and Lee, Hyo-Jung and Kim, Jin Woo and Park, Seung Shin and Kim, Sang Wan and Shin, Chan Soo and Song, Tae-Jin},
  title = {Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae850}
}
Kostenlos starten →